Literature DB >> 22634294

Waning population immunity to measles in Taiwan.

Chih-Jung Chen1, Ping-Ing Lee, Yu-Chia Hsieh, Po-Yen Chen, Yu-Huai Ho, Chee-Jen Chang, Ding-Ping Liu, Feng-Yee Chang, Cheng-Hsun Chiu, Yhu-Chering Huang, Chin-Yun Lee, Tzou-Yien Lin.   

Abstract

To evaluate the population immunity to measles in Taiwan where the coverage rate of the measles vaccine was >95% for more than a decade, anti-measles IgG was determined in 3552 Taiwanese volunteers in 2007. The overall seroprevalence was 74.7% (95% confidence interval [CI]: 73.3-76.1%). In subgroups aged 2-25 years, to whom at least 2 doses of measles-containing vaccine were given, there was a declining trend of seropositivity with age from 94.5% at 2 years to 50.6% at 21-25 years (p<0.0001). Age (odds ratio [OR]: 1.0464, 95% CI: 1.043-1.085) and male gender (OR: 1.466, 95% CI: 1.131-1.901) were independent factors predicting seronegative sera in this population. Seroprevalence was uniformly >95% in the older population (≥ 35 years) who had not been immunized against measles. The waning vaccine-induced immunity may have impact on the control of measles in the future, especially when the vaccinated population becomes older.
Copyright © 2012. Published by Elsevier Ltd.

Mesh:

Substances:

Year:  2012        PMID: 22634294     DOI: 10.1016/j.vaccine.2012.05.019

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  An assessment of measles vaccine effectiveness, Australia, 2006-2012.

Authors:  Alexis Pillsbury; Helen Quinn
Journal:  Western Pac Surveill Response J       Date:  2015-07-09

2.  In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence.

Authors:  T N Figueira; L M Palermo; A S Veiga; D Huey; C A Alabi; N C Santos; J C Welsch; C Mathieu; B Horvat; S Niewiesk; A Moscona; M A R B Castanho; M Porotto
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China.

Authors:  Yongzhen Xiong; Dong Wang; Weiyan Lin; Hao Tang; Shaoli Chen; Jindong Ni
Journal:  Hum Vaccin Immunother       Date:  2014-01-21       Impact factor: 3.452

Review 4.  Challenges for nationwide vaccine delivery in African countries.

Authors:  Mario Songane
Journal:  Int J Health Econ Manag       Date:  2017-10-19

5.  Association of persistent wild-type measles virus RNA with long-term humoral immunity in rhesus macaques.

Authors:  Ashley N Nelson; Wen-Hsuan W Lin; Rupak Shivakoti; Nicole E Putnam; Lisa Mangus; Robert J Adams; Debra Hauer; Victoria K Baxter; Diane E Griffin
Journal:  JCI Insight       Date:  2020-02-13

Review 6.  Measles Vaccine.

Authors:  Diane E Griffin
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

7.  Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010: the effect of high coverage with two doses of measles vaccine among children.

Authors:  Yuanbao Liu; Peishan Lu; Ying Hu; Zhiguo Wang; Xiuying Deng; Fubao Ma; Hong Tao; Chengmei Jia; Xiaoyan Ding; Haitao Yang; Pei Liu; Jie Min
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

8.  Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides.

Authors:  C Mathieu; D Huey; E Jurgens; J C Welsch; I DeVito; A Talekar; B Horvat; S Niewiesk; A Moscona; M Porotto
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

9.  Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreak.

Authors:  Ravit Bassal; Victoria Indenbaum; Rakefet Pando; Tal Levin; Eilat Shinar; Doron Amichay; Mira Barak; Anat Ben-Dor; Adina Bar Haim; Ella Mendelson; Dani Cohen; Tamy Shohat
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

10.  The epidemiological and serological characteristics of measles in Dongguan, China, 2005-2014.

Authors:  Ke Han; Shaoli Chen; Cuifei Tang; Jinjun Wen; Jingquan Li; Jindong Ni; Xueli Zheng
Journal:  Hum Vaccin Immunother       Date:  2016-03-22       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.